Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 5/2006

01-05-2006 | Original Article

Increased health care utilisation among 10-year breast cancer survivors

Authors: L. V. van de Poll-Franse, F. Mols, A. J. J. M. Vingerhoets, A. C. Voogd, R. M. H. Roumen, J. W. W. Coebergh

Published in: Supportive Care in Cancer | Issue 5/2006

Login to get access

Abstract

Objective

We investigated self-reported health care utilisation of women who survived breast cancer for 10 years and identified predictors of health care utilisation.

Methods

The population-based Eindhoven Cancer Registry was used to select all women who were diagnosed with breast cancer in 1993, in six hospitals in the Netherlands, and were disease-free at the time of data collection. Health status, psychological well-being, satisfaction with life and health care use were compared with same age controls. Logistic regression was used to identify predictors of health care utilisation.

Results

Of the 254 women who were sent a questionnaire, 183 (72%) responded. Breast cancer survivors had a similar health status and psychological well-being and a better satisfaction with life compared to same age controls. The proportion of breast cancer survivors (79%) who visited a specialist in the past 12 months was significantly higher compared to controls (53%). Young breast cancer survivors (45–54 at time of completing questionnaire) more often visited a physical therapist (56%) or complementary caregiver (26%) than controls (29 and 13%, respectively). Spontaneously reported problems (fatigue, arm problems) as a consequence of cancer and co-morbidity showed the strongest associations with health care utilisation.

Conclusions

Although self-reported health, satisfaction with life and psychological well-being were similar or even better in long-term breast cancer survivors compared to those in population controls, survivors more often attended a specialist, physical therapist and complementary caregiver in the past 12 months. Survivors of young age appear to have the highest use of health care services compared to age-matched controls, especially related to fatigue and arm problems.
Literature
1.
Ganz PA (2003) Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory. Eur J Cancer 39:2136–2141PubMedCrossRef
2.
Cancer in the Netherlands (2004) Trends, prognoses, and implications for healthcare. Dutch Cancer Society-Cancer Watch Committee, The Netherlands
3.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18(4):743–753PubMed
4.
Thors CL, Broeckel JA, Jacobsen PB (2001) Sexual functioning in breast cancer survivors. Cancer Control 8(5):442–448PubMed
5.
Ferrell BR, Grant MM, Funk BM, Otis-Green SA, Garcia NJ (1998) Quality of life in breast cancer survivors: implications for developing support services. Oncol Nurs Forum 25(5):887–895PubMed
6.
Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT (2002) Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 137(11):1253–1257PubMedCrossRef
7.
Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA (2003) Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 90(1):76–81PubMedCrossRef
8.
Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA et al (2001) Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37(8):991–999PubMedCrossRef
9.
Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94(1):39–49PubMed
10.
Amir M, Ramati A (2002) Post-traumatic symptoms, emotional distress and quality of life in long-term survivors of breast cancer: a preliminary research. J Anxiety Disord 16(2):195–206PubMedCrossRef
11.
Van Heck GL, Vingerhoets AJJM (2001) The CentERdata Health monitor: development and first results. Tilburg University, Tilburg
12.
Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV (2005) Quality of life in long-term breast cancer survivors: a systematic review. Eur J Cancer 41:2613–2619PubMedCrossRef
13.
Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66(1):136–138PubMed
14.
Kornblith AB, Herndon JE II, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S et al (2003) Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 98(4):679–689PubMedCrossRef
15.
Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B et al (1998) Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 83(7):1362–1368PubMedCrossRef
16.
Hack TF, Cohen L, Katz J, Robson LS, Goss P (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17(1):143–149PubMed
17.
Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B (1998) Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol 16(2):487–494PubMed
18.
Jacobsen PB, Stein K (1999) Is fatigue a long-term side effect of breast cancer treatment? Cancer Control 6(3):256–263PubMed
19.
Mor V, Allen S, Malin M (1994) The psychosocial impact of cancer on older versus younger patients and their families. Cancer 74(7 Suppl):2118–2127PubMedCrossRef
20.
Westert GP, Satariano WA, Schellevis FG, van den Bos GA (2001) Patterns of comorbidity and the use of health services in the Dutch population. Eur J Public Health 11(4):365–372PubMedCrossRef
21.
Seo PH, Pieper CF, Cohen HJ (2004) Effects of cancer history and comorbid conditions on mortality and healthcare use among older cancer survivors. Cancer 101(10):2276–2284PubMedCrossRef
22.
Nord C, Mykletun A, Thorsen L, Bjoro T, Fossa SD (2005) Self-reported health and use of health care services in long-term cancer survivors. Int J Cancer 114(2):307–316PubMedCrossRef
23.
Earle CC, Burstein HJ, Winer EP, Weeks JC (2003) Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 21(8):1447–1451PubMedCrossRef
24.
Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME et al (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29(4):341–350PubMedCrossRef
25.
Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88(3):608–614PubMedCrossRef
26.
Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM (2002) Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9(8):745–753PubMedCrossRef
27.
Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18(13):2515–2521PubMed
28.
Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246–252PubMedCrossRef
29.
Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309(6947):86–89PubMed
30.
Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340(22):1733–1739PubMedCrossRef
31.
Meyer L, Aspegren K (1989) Long-term psychological sequelae of mastectomy and breast-conserving treatment for breast cancer. Acta Oncol 28(1):13–18PubMedCrossRef
Metadata
Title
Increased health care utilisation among 10-year breast cancer survivors
Authors
L. V. van de Poll-Franse
F. Mols
A. J. J. M. Vingerhoets
A. C. Voogd
R. M. H. Roumen
J. W. W. Coebergh
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0007-4

Other articles of this Issue 5/2006

Supportive Care in Cancer 5/2006 Go to the issue

Editorial

Unmet needs of cancer survivors: supportive care’s new challenge

Original Article

Polymerase chain reaction screening for fungemia and/or invasive fungal infections in patients with hematologic malignancies

Special Article

Teaching communication and stress management skills to junior physicians dealing with cancer patients: a Belgian Interuniversity Curriculum

Forthcoming Meetings

Forthcoming meetings

Short Communication

N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data

Short Communication

Atypical pulmonary embolism of port catheter fragments in oncology patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits